Valuation: MedPacto, Inc.

Market Cap 125B 93.38M 85.05M 78.37M 71.29M 134M 8.65B 141M 954M 379M 4.72B 350M 343M 14.82B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 86.3B 64.33M 58.59M 53.99M 49.11M 92.13M 5.96B 96.83M 657M 261M 3.25B 241M 236M 10.21B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-2.66%
1 week-14.20%
Current month+19.84%
1 month+7.82%
3 months+41.12%
6 months-8.62%
Current year-45.28%
1 week 3,585
Extreme 3585.00000000
4,340
1 month 2,865
Extreme 2865
5,100
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,210
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 18/06/2013
President 66 27/03/2024
Comptroller/Controller/Auditor 70 27/03/2022
Director TitleAgeSince
Director/Board Member 72 18/06/2013
Director/Board Member 66 27/03/2024
Director/Board Member 64 27/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy 10,000 0.0292%
04/03/25 Buy 10,500 0.0306%
04/03/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-2.66%-14.20%-51.33%-52.10% 93.38M
-2.49%-3.76%+50.31%+62.10% 63.66B
-0.63%-2.91%+6.20%+89.22% 58.56B
-2.37%-2.22%+22.87%+82.31% 54.19B
-2.19%-6.15%+11.92%+108.08% 44.66B
-1.89%-7.28%+13.22%+19.74% 40.51B
-0.93%-0.47%+19.73%+43.75% 36.27B
+1.11%-6.44%+130.68%+641.83% 34.89B
-0.80%+0.61%+77.26%+56.26% 32.26B
-2.17%+16.65%-29.21%+474.05% 31.01B
Average -1.50%-1.70%+25.17%+152.52% 40B
Weighted average by Cap. -1.48%-1.94%+32.14%+150.85%

Financials

2024 2025
Net sales - 3.9K 2.91 2.65 2.44 2.22 4.16 269.09 4.37 29.68 11.8 146.98 10.9 10.67 461.27
Net income -20.14B -15.01M -13.67M -12.6M -11.46M -21.5M -1.39B -22.6M -153M -60.95M -759M -56.33M -55.14M -2.38B -12.81B -9.55M -8.7M -8.01M -7.29M -13.68M -884M -14.37M -97.54M -38.77M -483M -35.83M -35.07M -1.52B
Net Debt -53.54B -39.91M -36.35M -33.49M -30.47M -57.16M -3.7B -60.07M -408M -162M -2.02B -150M -147M -6.33B -38.97B -29.05M -26.46M -24.38M -22.18M -41.61M -2.69B -43.73M -297M -118M -1.47B -109M -107M -4.61B
Projected Income Statement - Annual - MedPacto, Inc.
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
56
Date Price Change Volume
20/11/26 ₩3,655.00 -2.66% 209,554
19/11/26 ₩3,755.00 +0.13% 191,160
18/11/26 ₩3,750.00 -2.34% 338,332
17/11/26 ₩3,840.00 -0.65% 372,915
16/11/26 ₩3,865.00 -9.27% 734,592
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - MedPacto, Inc.
  1. Stock Market
  2. Stocks
  3. A235980 Stock